TORONTO, May 11, 2023 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities", "MFC" or the "Corporation") announced that the nominees listed in the management information circular for the 2023 Annual Meeting of Shareholders (the "Meeting") held on May 11, 2023 via online webcast were elected as directors of the Corporation.
Detailed results of the votes by proxy and ballot for the election of directors are set out below.
Nominee | Votes | % of Votes | Votes | % of Votes |
Yanick Blanchard | 11,476,724 | 99.51 % | 57,004 | 0.49 % |
Erin S. Enright | 11,475,663 | 99.50 % | 58,065 | 0.50 % |
Michael V. Gisser | 11,383,897 | 98.70 % | 149,831 | 1.30 % |
Jason P. Redman | 11,469,553 | 99.44 % | 64,175 | 0.56 % |
Reza Shahim | 11,463,762 | 99.39 % | 69,966 | 0.61 % |
Adina G. Storch | 11,474,244 | 99.48 % | 59,484 | 0.52 % |
At the Meeting, the shareholders of the Corporation also approved the appointment of Grant Thornton LLP as auditors of the Corporation and authorized the board of directors of the Corporation to fix their remuneration, with 99.08% of the votes in favour.
Medical Facilities, in partnership with physicians, owns a portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. In addition, through a partnership with NueHealth LLC, Medical Facilities owns a controlling interest in five ambulatory surgery centers located in Michigan, Missouri, Nebraska, Ohio, and Pennsylvania. MFC also owns a non-controlling interest in an ASC in Missouri. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASCs specialize in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.
Caution concerning forward-looking statements
Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties. Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Factors that could cause results to vary include those identified in Medical Facilities' filings with Canadian securities regulatory authorities such as legislative or regulatory developments, intensifying competition, technological change and general economic conditions. All forward-looking statements presented herein should be considered in conjunction with such filings. Medical Facilities does not undertake to update any forward-looking statements; such statements speak only as of the date made.
Last Trade: | C$15.87 |
Daily Change: | 0.43 2.78 |
Daily Volume: | 59,633 |
Market Cap: | C$372.790M |
November 07, 2024 August 06, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB